These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1479708)

  • 21. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
    Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
    Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
    Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2006; 57(4):193-8. PubMed ID: 17285762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH.
    Yamamoto S; Yamaguchi I; Hasegawa K; Tsutsumi S; Goto Y; Gejyo F; Naiki H
    J Am Soc Nephrol; 2004 Jan; 15(1):126-33. PubMed ID: 14694164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH.
    Yamaguchi I; Hasegawa K; Takahashi N; Gejyo F; Naiki H
    Biochemistry; 2001 Jul; 40(29):8499-507. PubMed ID: 11456487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized beta 2-microglobulin deposition. A preamyloidosis disorder?
    Terreros DA; Knight JA; Peric-Golia L; Cheung AK
    Arch Pathol Lab Med; 1989 Jan; 113(1):31-5. PubMed ID: 2491942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
    Gouin-Charnet A; Mourad G; Argilés A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.
    Naiki H; Yamamoto S; Hasegawa K; Yamaguchi I; Goto Y; Gejyo F
    Amyloid; 2005 Mar; 12(1):15-25. PubMed ID: 16076607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis.
    Campistol JM; Bernard D; Papastoitsis G; Solé M; Kasirsky J; Skinner M
    Kidney Int; 1996 Oct; 50(4):1262-7. PubMed ID: 8887286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deposition of kappa and lambda light chains in amyloid filaments of dialysis-related amyloidosis.
    Brancaccio D; Ghiggeri GM; Braidotti P; Garberi A; Gallieni M; Bellotti V; Zoni U; Gusmano R; Coggi G
    J Am Soc Nephrol; 1995 Oct; 6(4):1262-70. PubMed ID: 8589295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [AA, AL and A beta 2M amyloidoses as seen by the rheumatologist].
    Gerster JC
    Rev Med Suisse Romande; 2000 Oct; 120(10):765-9. PubMed ID: 11109904
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-2-microglobulin-derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients.
    Stein G; Schneider A; Thoss K; Ritz E; Linke RP; Schaefer K; Sperschneider H; Abendroth K; Fünfstück R
    Nephron; 1992; 60(3):274-80. PubMed ID: 1565179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pattern of amyloid deposition in the lung.
    Looi LM
    Malays J Pathol; 1999 Jun; 21(1):29-35. PubMed ID: 10879276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A histological study on the synovial tissue of rat knee joints in the experimental beta 2-microglobulin derived amyloidosis].
    Ueda T
    Ryumachi; 1992 Aug; 32(4):308-17. PubMed ID: 1411793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease.
    Casey TT; Stone WJ; DiRaimondo CR; Brantley BD; DiRaimondo CV; Gorevic PD; Page DL
    Hum Pathol; 1986 Jul; 17(7):731-8. PubMed ID: 3087858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Affinity binding of glycosaminoglycans with beta(2)-microglobulin.
    Ohashi K; Kisilevsky R; Yanagishita M
    Nephron; 2002 Feb; 90(2):158-68. PubMed ID: 11818700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular involvement and cell damage in experimental AA and clinical beta(2)-microglobulin amyloidosis.
    García-García M; Mourad G; Durfort M; García-Valero J; Argilés A
    Nephrol Dial Transplant; 2002 Aug; 17(8):1450-6. PubMed ID: 12147793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features.
    Ohyama T; Shimokama T; Yoshikawa Y; Watanabe T
    Mod Pathol; 1990 Jul; 3(4):419-22. PubMed ID: 2217149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
    Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
    Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
    Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
    Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.